Teva Pharmaceutical Industries (TEVA) Receivables - Net (2009 - 2026)
Teva Pharmaceutical Industries' Receivables - Net was $3.49 billion in Q2 2026, down 2.0% from $3.56 billion a year earlier but up 2.9% from the prior quarter.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Receivables - Net (2009 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Net at Teva Pharmaceutical Industries came in at $3.71 billion, up 21.2% from FY2024.
- Receivables - Net shows a five-year compound annual growth rate of -4.1% (FY2020 to FY2025).
- In earlier years, Receivables - Net was $3.06 billion in FY2024 (-10.2%), $3.41 billion in FY2023 (-7.8%), $3.7 billion in FY2022 (-18.4%) and $4.53 billion in FY2021 (-1.1%).
- Quarterly Receivables - Net has moved between $3.06 billion (Q4 2024) and $4.53 billion (Q4 2021) over five years.
- Compared with a year earlier, Receivables - Net was higher in four of the last eight quarters, with growth averaging 1.8%.
- The best year-over-year quarter for Receivables - Net over five years was Q4 2025 (growth of 21.2%); the worst was Q2 2023 (a decline of 20.8%).
- Per Business Quant data, TEVA's Receivables - Net in the three quarters before Q2 2026 was $3.39 billion (Q1 2026), $3.71 billion (Q4 2025) and $3.81 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Teva Pharmaceutical Industries | 45.31 Bn | 32.16 Bn | 2.15 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.49 Bn |
| Mar 31, 2026 | 3.39 Bn |
| Dec 31, 2025 | 3.71 Bn |
| Sep 30, 2025 | 3.81 Bn |
| Jun 30, 2025 | 3.56 Bn |
| Mar 31, 2025 | 3.38 Bn |
| Dec 31, 2024 | 3.06 Bn |
| Sep 30, 2024 | 3.46 Bn |
| Jun 30, 2024 | 3.77 Bn |
| Mar 31, 2024 | 3.46 Bn |
| Dec 31, 2023 | 3.41 Bn |
| Sep 30, 2023 | 3.39 Bn |
| Jun 30, 2023 | 3.54 Bn |
| Mar 31, 2023 | 3.44 Bn |
| Dec 31, 2022 | 3.70 Bn |
| Sep 30, 2022 | 3.73 Bn |
| Jun 30, 2022 | 4.47 Bn |
| Mar 31, 2022 | 4.25 Bn |
| Dec 31, 2021 | 4.53 Bn |
| Sep 30, 2021 | 4.05 Bn |
API Access
Teva Pharmaceutical Industries Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();